October 2011

Inhaltsverzeichnis Anzeigen

Smart Approach to Testing Needed For Fragile X Syndrome

A widely available but underused molecular genetic blood test has proved to be accurate over 98% of the time and costs less than $400
This is no one-size-fits-all solution, as insurers across the country tailor efforts for specific markets
Once in a while something comes up that requires the sort of immediate and intense intervention that’s downright heroic
Lax regulations and fee-for-service payment make an irresistible mix for physician conflicts. Are ACOs the answer?
Medco’s ‘gaps in care’ approach saves $900 million by targeting 15 chronic conditions

COVER STORY

VBID is a promising approach to improving health and cost outcomes, but its use has been limited. Expanding it to complicated interventions will require a lot of effort.

EVIDENCE REVIEW

A summary of the ECRI Institute’s Emerging Technology Evidence Report

Q&A

The National Business Group on Health’s CEO looks for employers and insurers to collaborate to improve patient safety and cut costs

LEGISLATION & REGULATION

The need for health plans to cut administrative costs is hammering insurance brokers. Is this another instance of the law of unintended consequences?

MANAGED CARE OUTLOOK

MEDICATION MANAGEMENT

Health plans are expanding MTM — once considered a Part D mainstay — to their commercial businesses.

PLAN WATCH

If UnitedHealth Group’s effort to buy a large physician group proves successful, clinical execs will have even more oversight

THE FORMULARY FILES

TOMORROW’S MEDICINE

Brilinta’s price will be a significant factor in coverage decisions when Plavix goes off patent in May 2012

VIEWPOINT

In a system where people will soon shop for their benefits on exchanges, plans that offer the best customer service will have the edge

NEWS AND COMMENTARY

NEWS AND COMMENTARY

NEWS AND COMMENTARY

NEWS AND COMMENTARY

NEWS AND COMMENTARY

NEWS AND COMMENTARY


Our most popular topics on Managedcaremag.com